COMMON STOCK (Details Narrative) - $ / shares |
12 Months Ended | ||||
|---|---|---|---|---|---|
Oct. 21, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Jun. 04, 2024 |
Jun. 03, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
| Common stock, shares authorized | 100,000,000 | 100,000,000 | 100,000,000 | 25,000,000 | |
| Common stock, par value per share | $ 0.007 | $ 0.007 | $ 0.007 | ||
| Shares issued | 2,048,294 | ||||
| Restricted Stock Units Unvested [Member] | |||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
| Unvested restricted stock | 349,057 | 110,645 | |||
| Common Stock [Member] | |||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
| Shares issued | 15,576,674 | 9,505,255 | |||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|